Cardiovascular disease is affecting millions of people worldwide and is the leading cause of death in the United States. This disease is closely related to the abnormal creatinine levels in blood. For this reason, there is a need for a low-cost point-of-care device that could measure the creatinine level in…
Cardiovascular disease is affecting millions of people worldwide and is the leading cause of death in the United States. This disease is closely related to the abnormal creatinine levels in blood. For this reason, there is a need for a low-cost point-of-care device that could measure the creatinine level in blood with the goal of managing and preventing cardiovascular disease. This project introduces a Molecular Reactive Lateral Flow Assay (MoReLFA) device that is aimed toward creatinine detection based on an optimized chemical reaction of creatinine and alkaline picrate. The device consists of different membranes that accommodate 50 microliters of fluid sample and carry out a colorimetric reaction, in which deposited-colored region is analyzed for Red, Green, and Blue (RGB) components via an image processing software. The color intensity from the RGB outputs was then studied and compared with a gold standard spectrophotometry-based technique. The results show that the MoReLFA sensor could successfully detect creatinine levels in standard solutions. The plot of the sensor color intensity against the absorbance from spectrophotometry shows a good correlation between the two methods (R2 = 0.96). Furthermore, the paper introduces the development of a RGB reader box that is portable and for easy assessment of RGB values. The color intensity from the box shows an increasing trend with increasing creatinine concentrations; and the coefficient of determination of this relationship is 0.85.
Realtime understanding of one’s complete metabolic state is crucial to controlling weight and managing chronic illnesses, such as diabetes. This project represents the development of a novel breath acetone sensor within the Biodesign Institute’s Center for Bioelectronics and Biosensors. The purpose is to determine if a sensor can be manufactured…
Realtime understanding of one’s complete metabolic state is crucial to controlling weight and managing chronic illnesses, such as diabetes. This project represents the development of a novel breath acetone sensor within the Biodesign Institute’s Center for Bioelectronics and Biosensors. The purpose is to determine if a sensor can be manufactured with the capacity to measure breath acetone concentrations typical of various levels of metabolic activity. For this purpose, a solution that selectively interacts with acetone was embedded in a sensor cartridge that is permeable to volatile organic compounds. After 30 minutes of exposure to a range of acetone concentrations, a color change response was observed in the sensors. Requiring only exposure to a breath, these novel sensor configurations may offer non-trivial improvements to clinical and at-home measurement of lipid metabolic rate.
